Macrophage activation syndrome (MAS) is a phenomenon characterized by cytopenia, organ dysfunction, and coagulopathy associated with an inappropriate activation of macrophages. Current diagnostic criteria are imprecise, but the syndrome is now recognized as a form of hemophagocytic lymphohistiocytosis that is characteristically associated with autoimmune diatheses. The diagnosis of incipient MAS in patients with autoimmune disease requires a high index of suspicion, as several characteristics of the disorder may be present in the underlying condition or infectious complications associated with the treatment thereof. Proposed treatment regimens include aggressive approaches that require validation in future controlled studies. This review discusses the major aspects of the pathophysiology, diagnosis, and management of MAS with a focus on the association with autoimmune disease.

Macrophage activation syndrome in autoimmune disease / S. Deane, C. Selmi, S.S. Teuber, M.E. Gershwin. - In: INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. - ISSN 1018-2438. - 153:2(2010), pp. 109-120. [10.1159/000312628]

Macrophage activation syndrome in autoimmune disease

C. Selmi
Secondo
;
2010

Abstract

Macrophage activation syndrome (MAS) is a phenomenon characterized by cytopenia, organ dysfunction, and coagulopathy associated with an inappropriate activation of macrophages. Current diagnostic criteria are imprecise, but the syndrome is now recognized as a form of hemophagocytic lymphohistiocytosis that is characteristically associated with autoimmune diatheses. The diagnosis of incipient MAS in patients with autoimmune disease requires a high index of suspicion, as several characteristics of the disorder may be present in the underlying condition or infectious complications associated with the treatment thereof. Proposed treatment regimens include aggressive approaches that require validation in future controlled studies. This review discusses the major aspects of the pathophysiology, diagnosis, and management of MAS with a focus on the association with autoimmune disease.
Lymphohistiocytosis, Hemophagocytic ; Autoimmune Diseases ; Killer Cells, Natural ; Humans ; CD8-Positive T-Lymphocytes ; Macrophage Activation ; Macrophage Activation Syndrome ; Rheumatic Diseases
Settore MED/09 - Medicina Interna
Settore MED/16 - Reumatologia
2010
Article (author)
File in questo prodotto:
File Dimensione Formato  
produkte.pdf

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 333.18 kB
Formato Adobe PDF
333.18 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/161417
Citazioni
  • ???jsp.display-item.citation.pmc??? 39
  • Scopus 97
  • ???jsp.display-item.citation.isi??? 86
social impact